Results 1 to 10 of about 964,082 (402)
Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity [PDF]
Vaccines, 2021 Influenza poses a huge threat to global public health. Influenza vaccines are the most effective and cost-effective means to control influenza. Current influenza vaccines mainly induce neutralizing antibodies against highly variable globular head of ...
Zhuofan Li +3 more
doaj +3 more sources
Cell culture-derived flu vaccine: Present and future [PDF]
Human Vaccines & Immunotherapeutics, 2018 The benefit of influenza vaccines is difficult to estimate due to the complexity of accurately assessing the burden of influenza. To improve the efficacy of influenza vaccines, vaccine manufacturers have developed quadrivalent influenza vaccine (QIV ...
Alberto Pérez Rubio, Jose María Eiros
doaj +2 more sources
The Usage of Influenza Vaccine to Prevent Seasonal Influenza during Pandemic COVID-19 [PDF]
Magna Medika, 2021 Influenza is an acute respiratory disease caused by influenza virus. Influenza can affect million people in every year and causing morbidity. Some of cases can be severe and need hospitalized, especially in elderly people.
Yelvi Levani, Ayu Lidya Paramita
doaj +3 more sources
Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. [PDF]
, 2013 BackgroundLittle is known on the effectiveness of influenza vaccine in ESRD patients. This study compared the incidence of hospitalization, morbidity, and mortality in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) between cohorts ...
Chang, Chiz-Tzung +9 more
core +20 more sources
Vaccines, 2021 Two reviews by Harding and Heaton [...]
Apostolos P. Georgopoulos +4 more
openaire +3 more sources
The relationship between influenza vaccine hesitancy and vaccine literacy among youth and adults in China [PDF]
Frontiers in ImmunologyObjectivesThe present study aimed to assess influenza vaccine hesitancy and vaccine literacy levels among youth and adults in China, as well as the association between them.MethodsAn online cross-sectional survey was conducted in Mainland China ...
Li Wang +6 more
doaj +2 more sources
Multivalent Epigraph Hemagglutinin Vaccine Protects against Influenza B Virus in Mice [PDF]
PathogensInfluenza B virus is a respiratory pathogen that contributes to seasonal epidemics, accounts for approximately 25% of global influenza infections, and can induce severe disease in young children.
Erika Petro-Turnquist +4 more
doaj +3 more sources
Pharmaceuticals, 2023 In 2019, EMA licensed intravenous (IV) zanamivir for severe influenza virus infection in children over 6 months as well as adults. Prior to that, it was possible via a compassionate use program.
Maren Alchikh +3 more
doaj +1 more source
Influenza Virus and Vaccination [PDF]
Pathogens, 2020 Influenza virus infections represent a serious public health problem causing contagious respiratory disease and substantial morbidity and mortality in humans, resulting in a considerable economic burden worldwide. Notably, the number of deaths due to influenza exceeds that of any other known pathogen.
Aitor Nogales, Marta L. DeDiego
openaire +5 more sources
Influenza and the influenza vaccine [PDF]
Canadian Medical Association Journal, 2007 Influenza, or the “flu,” is an infection caused by the influenza virus. The virus infects the nose and throat, and it can sometimes spread to the lungs. Influenza commonly causes acute fever, cough, chills, tiredness, body aches and, in young children, ear aches.
Joanne M. Langley +2 more
openaire +3 more sources